Legislative record

SB 421STATE · TennesseeIntroduced

Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Voted 4/28/2025View source

Summary

No summary has been published for this bill yet.

Bill text

The full text of this bill isn't on Heard yet. The official documents are linked below.

Roll-call record

How representatives voted

9 yea·0 nay

Docket history

Action history

  1. 4/28/2025Comp. became Pub. Ch. 295
  2. 4/7/2025Sponsor(s) Added.
  3. 4/7/2025Companion House Bill substituted
  4. 4/4/2025Placed on Senate Regular Calendar for 4/7/2025
  5. 4/3/2025Senate Reset on calendar for 4/7/2025
  6. 4/1/2025Placed on Senate Regular Calendar for 4/3/2025
  7. 3/31/2025Sponsor(s) Added.
  8. 3/31/2025Senate Reset on calendar for 4/3/2025
  9. 3/28/2025Placed on Senate Regular Calendar for 3/31/2025
  10. 3/24/2025Sponsor(s) Added.